Literature DB >> 9792149

Superoxide dismutases in relation to the overall survival of colorectal cancer patients.

A M Janssen1, C B Bosman, C F Sier, G Griffioen, F J Kubben, C B Lamers, J H van Krieken, C J van de Velde, H W Verspaget.   

Abstract

Reactive oxygen metabolites are implicated in the initiation and promotion of cancer. In addition, oxidant scavengers, such as manganese--(Mn-SOD) and copper/zinc--superoxide dismutase (Cu/Zn-SOD), are thought to contribute to colorectal cancer treatment response. In the present study, the prognostic significance of the Mn- and Cu/Zn-SOD antigen content of normal mucosa and carcinomas of 163 patients with colorectal cancer was evaluated in comparison with major clinicopathological parameters, with respect to the 5-year overall survival. The Mn-SOD content of carcinomas was found to be significantly higher than that of normal mucosa, whereas there was no difference in the Cu/Zn-SOD content between the normal mucosa and carcinomas. No association was demonstrable between the Mn-SOD and Cu/Zn-SOD content of the tissues and the assessed clinicopathological parameters (gender, age, localization, differentiation grade, diameter and Dukes' stage), with the exception of the Cu/Zn-SOD and the differentiation grade of the carcinomas. Univariate analysis showed that a high Mn-SOD content of carcinomas was associated with a poor 5-year overall survival of the patients with colorectal cancer. Multivariate analysis including all clinicopathological parameters revealed that this Mn-SOD parameter was prognostically independent. The Mn- and Cu/Zn-SOD content of normal mucosa and the Cu/Zn-SOD content of carcinomas were not associated with the overall survival of the patients. In conclusion, this study demonstrates that for patients with colorectal cancer the Mn-SOD content of colorectal carcinomas has a significant prognostic value that is independent from major clinicopathological parameters, including Dukes' stage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792149      PMCID: PMC2063153          DOI: 10.1038/bjc.1998.626

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

Review 1.  Superoxide dismutases.

Authors:  I Fridovich
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  The prognostic significance of direct extension of carcinoma of the colon and rectum.

Authors:  V B ASTLER; F A COLLER
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

Review 3.  Superoxide dismutases.

Authors:  W Beyer; J Imlay; I Fridovich
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1991

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 5.  Role of superoxide dismutase in cancer: a review.

Authors:  L W Oberley; G R Buettner
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

6.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

Review 7.  Free-radical mechanisms in tissue injury.

Authors:  T F Slater
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

Review 8.  Antioxidant enzyme levels in cancer.

Authors:  T D Oberley; L W Oberley
Journal:  Histol Histopathol       Date:  1997-04       Impact factor: 2.303

9.  Gastric mucosal superoxide dismutases in Helicobacter pylori infection.

Authors:  J M Götz; C I van Kan; H W Verspaget; I Biemond; C B Lamers; R A Veenendaal
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

10.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Authors:  J R Jass; W S Atkin; J Cuzick; H J Bussey; B C Morson; J M Northover; I P Todd
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

View more
  28 in total

1.  Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.

Authors:  Fengwei Tan; Ying Jiang; Nan Sun; Zhaoli Chen; Yongzhuang Lv; Kang Shao; Ning Li; Bin Qiu; Yibo Gao; Baozhong Li; Xiaogang Tan; Fang Zhou; Zhen Wang; Dapeng Ding; Jiwen Wang; Jian Sun; Jie Hang; Susheng Shi; Xiaoli Feng; Fuchu He; Jie He
Journal:  Mol Cell Proteomics       Date:  2011-11-07       Impact factor: 5.911

2.  A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.

Authors:  Jianqing Lin; Marianna Zahurak; Tomasz M Beer; Charles J Ryan; George Wilding; Paul Mathew; Michael Morris; Jennifer A Callahan; Gilad Gordon; Steven D Reich; Michael A Carducci; Emmanuel S Antonarakis
Journal:  Urol Oncol       Date:  2011-08-04       Impact factor: 3.498

3.  Expression and potential role of apolipoprotein D on the death-survival balance of human colorectal cancer cells under oxidative stress conditions.

Authors:  Raquel Bajo-Grañeras; Jesús Crespo-Sanjuan; Rosa M García-Centeno; José Antonio Garrote-Adrados; Gabriel Gutierrez; Manuel García-Tejeiro; Beatriz Aguirre-Gervás; María D Calvo-Nieves; Rosa Bustamante; Maria D Ganfornina; Diego Sanchez
Journal:  Int J Colorectal Dis       Date:  2013-01-08       Impact factor: 2.571

4.  Alteration of extracellular superoxide dismutase expression is associated with an aggressive phenotype of oral squamous-cell carcinoma.

Authors:  Hidetaka Yokoe; Hitomi Nomura; Yukio Yamano; Kazuaki Fushimi; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hiroki Bukawa; Katsuhiro Uzawa; Yuichi Takiguchi; Hideki Tanzawa
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

5.  Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells.

Authors:  Yong Xu; Fang Fang; Sanjit K Dhar; Antonio Bosch; William H St Clair; Edward J Kasarskis; Daret K St Clair
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

6.  Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma.

Authors:  Xiqiang Liu; Anxun Wang; Lorenzo Lo Muzio; Antonia Kolokythas; Shihu Sheng; Corrado Rubini; Hui Ye; Fei Shi; Tianwei Yu; David L Crowe; Xiaofeng Zhou
Journal:  BMC Cancer       Date:  2010-07-09       Impact factor: 4.430

Review 7.  Manganese superoxide dismutase in cancer prevention.

Authors:  Delira Robbins; Yunfeng Zhao
Journal:  Antioxid Redox Signal       Date:  2013-07-18       Impact factor: 8.401

8.  Superoxide dismutase is regulated by LAMMER kinase in Drosophila and human cells.

Authors:  Brian P James; William D Staatz; Sarah T Wilkinson; Emmanuelle Meuillet; Garth Powis
Journal:  Free Radic Biol Med       Date:  2008-12-24       Impact factor: 7.376

9.  Altered redox status accompanies progression to metastatic human bladder cancer.

Authors:  Nadine Hempel; Hanqing Ye; Bryan Abessi; Badar Mian; J Andres Melendez
Journal:  Free Radic Biol Med       Date:  2008-10-01       Impact factor: 7.376

10.  Nuclear oxidative damage correlates with poor survival in colorectal cancer.

Authors:  J Sheridan; L-M Wang; M Tosetto; K Sheahan; J Hyland; D Fennelly; D O'Donoghue; H Mulcahy; J O'Sullivan
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.